Daegu, South Korea

Ji-Hoon Yu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Daegu-Gyeongbuk Medical Innovation Foundation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ji-Hoon Yu. Retrieved from https://idiyas.com/inventor/ji-hoon-yu-ffs5mx1l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ji-Hoon Yu: Innovator in Medical Research

Introduction

Ji-Hoon Yu is a notable inventor based in Daegu, South Korea. He is currently associated with the Daegu-Gyeongbuk Medical Innovation Foundation. His work focuses on developing innovative solutions in the medical field, particularly in relation to EZH2-associated diseases.

Latest Patent Applications

Ji-Hoon Yu has filed a patent application titled "Compound Comprising EZH2 Inhibitor and E3 Ligase Binder and Pharmaceutical Composition for Preventing or Treating EZH2-Associated Disease Comprising Same as Active Ingredient." This invention relates to a compound that includes an EZH2 inhibitor and an E3 ligase binder. The pharmaceutical composition aims to prevent or treat diseases associated with EZH2, particularly cancers where EZH2 is overexpressed. The compound can selectively degrade EZH2, making it a promising candidate for targeted cancer therapies.

Conclusion

Ji-Hoon Yu's contributions to medical research highlight the potential for innovative treatments in the fight against cancer and other diseases. His ongoing work at the Daegu-Gyeongbuk Medical Innovation Foundation is paving the way for future advancements in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…